Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Chung‐Yi Wu, Cheng‐Wei Cheng, Chih‐Chuan Kung, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 35

Showing 26-50 of 35 citing articles:

Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in Escherichia coli
Intan Aghniya Safitri, Yovin Sugijo, Fernita Puspasari, et al.
Vaccine X (2024) Vol. 16, pp. 100443-100443
Open Access | Times Cited: 1
Impact of glycosylation on viral vaccines
Antonio Lembo, Antonio Molinaro, Cristina De Castro, et al.
Carbohydrate Polymers (2024) Vol. 342, pp. 122402-122402
Closed Access | Times Cited: 1
Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants
Man Xing, Yihan Wang, Xinyu Wang, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 4
Role of surface glycans in enveloped RNA virus infections: A structural perspective
Bhawna Pandey, S. Srividhya, Ananya Chatterjee, et al.
Proteins Structure Function and Bioinformatics (2023)
Closed Access | Times Cited: 2
S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern
Chang-Kyu Heo, Won-Hee Lim, Ki-Beom Moon, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 676-676
Open Access
Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies
Frances Rocamora, Angelo G. Peralta, Seunghyeon Shin, et al.
(2023)
Open Access | Times Cited: 1
D614G and Omicron SARS-CoV-2 variant spike proteins differ in the effects of N-glycan modifications on spike expression, virus infectivity, and neutralization by some therapeutic antibodies
Sabrina Lusvarghi, Charles B. Stauft, Russell Vassell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Impact of mutations on the plant-based production of recombinant SARS-CoV-2 RBDs
Valentina Ruocco, Ulrike Vavra, Julia König-Beihammer, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 1
Potential to Eradicate Cancer Stemness by Targeting Cell Surface GRP78
Hsin-Ying Chen, Ann‐Joy Cheng
Biomolecules (2022) Vol. 12, Iss. 7, pp. 941-941
Open Access | Times Cited: 2
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Previous Page - Page 2

Scroll to top